Nuvalent

Founder Matthew Shair
Founder Matthew Shair
USA | Funding: $749.5M (+)

Website: https://www.nuvalent.com/

Nuvalent is a biotechnology company that develops targeted therapies for clinically proven kinase targets in cancer.